Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 22/12/2011
PIL Fosamax

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 11/11/2011 and displayed until 22/12/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/04/2011 and displayed until 11/11/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
Updated on 30/03/2010 and displayed until 04/04/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to dosage and administration
Updated on 08/08/2008 and displayed until 30/03/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 05/03/2007 and displayed until 08/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 23/01/2006 and displayed until 05/03/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 06/05/2004 and displayed until 23/01/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 21/12/2001 and displayed until 06/05/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 18/07/2001 and displayed until 21/12/2001
Reasons for adding or updating:
  • Update to PIL
Updated on 17/08/2000 and displayed until 18/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   alendronate sodium